SAKAR HEALTHCARE
Quarterly Results Analysis [Dec2023]
SAKAR HEALTHCARE Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 Audited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
Sep2022 Audited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹37 Cr | ₹34 Cr | ₹39 Cr | ₹41 Cr | ₹33 Cr | ₹31 Cr | ₹29 Cr | ₹37 Cr |
Expenses | ₹28 Cr | ₹25 Cr | ₹30 Cr | ₹33 Cr | ₹25 Cr | ₹22 Cr | ₹21 Cr | ₹27 Cr |
Operating Income | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹8 Cr | ₹9 Cr | ₹9 Cr | ₹8 Cr | ₹9 Cr |
Other Income | ₹0 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr |
Interest | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Depreciation | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr |
Profit Before Tax | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹6 Cr |
Profit After Tax | ₹2 Cr | ₹4 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹2 Cr | ₹3 Cr | ₹9 Cr |
EPS | ₹0.95 | ₹1.70 | ₹1.49 | ₹2.06 | ₹2.16 | ₹1.04 | ₹1.68 | ₹5.23 |
Industry Peers & Returns | 1W | 1M | 1Y |
SAKAR HEALTHCARE | -2% | -6.7% | 62% |
SUN PHARMACEUTICAL INDUSTRIES | 0.3% | -7.5% | 53.9% |
CIPLA | 1.1% | -4.8% | 56.4% |
DR REDDYS LABORATORIES | 1.6% | 1.6% | 27.6% |
ZYDUS LIFESCIENCES | 5.2% | -0.2% | 90.1% |
DIVIS LABORATORIES | -1.9% | 10.7% | 21.4% |
MANKIND PHARMA | -2.3% | 0.1% | NA |
TORRENT PHARMACEUTICALS | 1.6% | 2% | 61.8% |
LUPIN | 2.4% | 2% | 132.5% |
SAKAR HEALTHCARE Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 9.23 % |
Y-o-Y | 11.24 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹37 Cr | 9.23 | |
Sep2023 | ₹34 Cr | -12.59 | |
Jun2023 | ₹39 Cr | -4.09 | |
Mar2023 | ₹41 Cr | 21.47 | |
Dec2022 | ₹33 Cr | 8.97 | |
Sep2022 | ₹31 Cr | 7.62 | |
Jun2022 | ₹29 Cr | -22.01 | |
Mar2022 | ₹37 Cr | - |
SAKAR HEALTHCARE Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -3.74 % |
Y-o-Y | 2.39 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹9 Cr | -3.74 | |
Sep2023 | ₹9 Cr | 3.69 | |
Jun2023 | ₹9 Cr | 15.98 | |
Mar2023 | ₹8 Cr | -11.56 | |
Dec2022 | ₹9 Cr | 2.31 | |
Sep2022 | ₹9 Cr | 8.09 | |
Jun2022 | ₹8 Cr | -12.58 | |
Mar2022 | ₹9 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -11.90 % |
Y-o-Y | -7.98 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 24.2% | -11.90 | |
Sep2023 | 27.47% | 18.66 | |
Jun2023 | 23.15% | 20.89 | |
Mar2023 | 19.15% | -27.19 | |
Dec2022 | 26.3% | -6.10 | |
Sep2022 | 28.01% | 0.43 | |
Jun2022 | 27.89% | 12.10 | |
Mar2022 | 24.88% | - |
SAKAR HEALTHCARE Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -42.94 % |
Y-o-Y | -48.32 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹2 Cr | -42.94 | |
Sep2023 | ₹4 Cr | 27.90 | |
Jun2023 | ₹3 Cr | -27.56 | |
Mar2023 | ₹4 Cr | -2.24 | |
Dec2022 | ₹4 Cr | 106.43 | |
Sep2022 | ₹2 Cr | -32.45 | |
Jun2022 | ₹3 Cr | -67.84 | |
Mar2022 | ₹9 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -47.80 % |
Y-o-Y | -53.54 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 5.57 % | -47.80 | |
Sep2023 | 10.67 % | 46.36 | |
Jun2023 | 7.29 % | -24.46 | |
Mar2023 | 9.65 % | -19.52 | |
Dec2022 | 11.99 % | 89.42 | |
Sep2022 | 6.33 % | -37.26 | |
Jun2022 | 10.09 % | -58.75 | |
Mar2022 | 24.46 % | - |
SAKAR HEALTHCARE Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -44.12 % |
Y-o-Y | -56.02 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹0.95 | -44.12 | |
Sep2023 | ₹1.7 | 14.09 | |
Jun2023 | ₹1.49 | -27.67 | |
Mar2023 | ₹2.06 | -4.63 | |
Dec2022 | ₹2.16 | 107.69 | |
Sep2022 | ₹1.04 | -38.10 | |
Jun2022 | ₹1.68 | -67.88 | |
Mar2022 | ₹5.23 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD